Cite
HARVARD Citation
Bautista, F. et al. (2021). Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial. Journal of clinical oncology. 39 (32), pp. 3546-3560. [Online].